Broncus Medical, Inc.

Broncus Medical, Inc. is a publicly traded global healthcare company based in San Jose, California. Founded in 1997, the company specializes in developing and commercializing medical devices aimed at diagnosing and treating lung diseases. With a workforce of approximately 77-315 employees, Broncus Medical holds a robust intellectual property portfolio, featuring around 75 patents. The company focuses on delivering advanced technologies for lung cancer diagnosis and emphysema treatment. Its key products include the Archimedes® System, a virtual bronchoscopic navigation system that enhances airway navigation, and the Archimedes® Lite, a streamlined version of this system. Other offerings include the Archimedes® Planner for procedural planning, the FleXNeedle® for lung procedures, and the Bronchoscopic Thermal Vapor Ablation® (InterVapor® or BTVA®), a non-surgical therapy for emphysema that promotes natural healing. In 2024, Broncus Medical reported annual revenue of $11 million, with significant growth in its Chinese market.